ARTICLE
A significant proportion of patients who suffer from depression do not respond to standard antidepressant treatment. Unfortunately, it is unclear what, for a given patient, works best as a next step, pharmacological treatment. This course highlights the recent progress in identifying new therapies for depressed patients who have not responded to standard antidepressants, including atypical antipsychotics, as well as glutamatergic and GABAergic compounds. Click here to access the Course of the Month and sign up for updates about this free member benefit.
A significant proportion of patients who suffer from depression do not respond to standard antidepressant treatment. Unfortunately, it is unclear what, for a given patient, works best as a next step, pharmacological treatment. This course highlights the recent progress in identifying new therapies for depressed patients who have not responded to standard antidepressants, including atypical antipsychotics, as well as glutamatergic and GABAergic compounds.
Click here to access the Course of the Month and sign up for updates about this free member benefit.